Filed with ASX · · 18 pages · English
Compumedics Limited has released an investor update for November, detailing a record revenue for the fiscal year and a new strategy to enhance the value of its research and development efforts. The update highlights significant achievements, including a return to profitability and improved cash flow, alongside a focus on recurring revenue from its SaaS products. Additionally, the company has outlined its plans for the upcoming fiscal year, emphasizing growth in its Somfit® product line and expansion into the US market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
C O M P U M E D I C S L I M I T E D ( A S X : C M P ) | I N V E S T O R U P D A T E | N O V E M B E R 2 0 2 6 Realising the value we have built A record FY26, and a new strategy to realise the captive value of our R&D — efficiently, and designed to be accretive for shareholders Dr David Burton...
